FilingSEC EDGAR424B5
PMV Pharmaceuticals Announces $47M Common Stock and Warrant Offering
· SEC accepted
StageOffering in progress
Filing content
PMV Pharmaceuticals is conducting an offering of common stock and pre-funded warrants to raise approximately $47 million in net proceeds, featuring conditional warrant exercise price adjustments based on FDA outcomes.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…